FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy
Zhoulei Li, Nicolas Graf, Ken Herrmann, Alexandra Jun, Michaela Aichler, Annette Feuchtinger, Anja Baumgart, Axel Walch, Christian Peschel, Markus Schwaiger, Andreas Buck, Ulrich Keller, Tobias Dechow
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
34Zitate
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy“. Zusammen bilden sie einen einzigartigen Fingerprint.